n-acetyl cysteine as a glutathione precursor for schizophrenia Item - precursor, N-acetyl-cysteine, improves mismatch negativity in patients - Deakin University Investigating the Effect of N-Acetyl
Investigating the Effect of N Acetyl Cysteine on Positive, Negative, and Cognitive Symptoms of Patients with Schizophrenia: A Clinical Trial Frontiers N acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) N acetylcysteine add on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double blind randomized placebo controlled trial Translational Psychiatry Exploring N Acetylcysteine in Psychiatry Psychiatric Times Glutathione Precursor, N Acetyl Cysteine, Improves Mismatch Negativity in Schizophrenia Patients Neuropsychopharmacology
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




